Kinapse Establishes US Operations and Appoints Tobias Hoppe as President, Kinapse US

Share Article

Kinapse has appointed Tobias Hoppe, formerly with Altana and Accenture, as President, Kinapse US to lead its expanding US operations.

Kinapse has appointed Tobias Hoppe, formerly with Altana and Accenture, as President, Kinapse US to lead its expanding US operations. Tobias has over 16 years of experience working in the life sciences industry. As a consultant with Accenture, he defined business strategies, developed operating models and led large-scale business reengineering projects for pharmaceutical companies headquartered both in the US and Europe.

He also led the High Performance Clinical Development Service Line for Austria, Switzerland, and Germany. Tobias was until recently the Head of R&D Project and Performance Management for Altana, a global pharmaceutical company focused on gastroenterology and inflammation. Tobias graduated magna cum laude from Rensselaer Polytechnic Institute in New York.

"I am excited to combine my consulting and pharmaceutical industry experience in growing Kinapse in this extremely important market," said Tobias of his appointment. "Kinapse, with its unique blend of onshore and offshore capabilities in consulting and information processing, is uniquely positioned to help global life sciences companies face the challenges placed on R&D."

Andy Black and Shalabh Kumar, the co-founders of Kinapse, commented, "The establishment of our US subsidiary and the appointment of Tobias Hoppe represents a major milestone in our business expansion. From the outset our intent has been to build a globally integrated company, able to serve our clients with local presence and global insight. We are delighted that Tobias and colleagues in the US have joined us and we look forward to serving our many US-headquartered clients from our base in Philadelphia."

About Kinapse:
"Collaborating with our clients to innovate for exceptional results."
Kinapse provides business consulting and information processing services to life sciences R&D organisations. Its clients include many of the world's leading pharmaceutical companies, leading biotechnology and specialty pharmaceutical companies, government organisations and industry service providers. Headquartered in the UK, Kinapse has offices in London, New Delhi and Philadelphia, with partners based in the Americas, Europe and Asia Pacific. Kinapse blends expertise from its multiple locations to deliver services for clients at highest quality and differentiated value.

The novel features of Kinapse's operating model include:

  • blended onshore-offshore teams, tailored to client requirements;
  • industry-veteran consulting partners who bring deep experience and expertise in specific functional areas;
  • exclusive service partners with distinctive, complementary services.

Contact
Shalabh Kumar, Chief Operating Officer
W: http://www.kinapse.com
P: +44 20 8946 7600

Kinapse Ltd.
Tuition House
27-37 St George's Road
Wimbledon
London SW19 4EU
UK

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

SHALABH KUMAR
Kinapse
020 89467600
Email >